Self-Assembling Peptides for Tooth Decay

Age: 18+
Sex: Any
Trial Phase: Phase 4
Sponsor: Tripler Army Medical Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Prior Safety DataThis treatment has passed at least one previous human trial

What You Need to Know Before You Apply

What is the purpose of this trial?

The primary objective of the protocol is to learn about how SAP P 11-4 (produced commercially as Curodont products) can be used in a military population to treat incipient dental caries, or developing cavities that are still structurally intact and not too deep and increase awareness of the improvement and availability of minimally invasive treatment options for cavities in a military population.

Who Is on the Research Team?

SP

Steven Phung, DMD

Principal Investigator

Tripler Army Medical Center

Are You a Good Fit for This Trial?

This trial is for military personnel who have early-stage cavities between their teeth that haven't yet caused significant damage. Participants should not have deep or advanced cavities.

Inclusion Criteria

Active Duty military
Must have time remaining on post for at least 4 months from the start of treatment/enrollment
I have at least one early-stage cavity between my teeth.

Exclusion Criteria

Tobacco, nicotine, and e-cigarette use
Non-active duty military
I have cavities between my teeth that are visible on X-rays.

What Are the Treatments Tested in This Trial?

Interventions

  • SAP P11-4

Trial Overview

The study tests a treatment using 0.05% sodium fluoride combined with self-assembling peptides (SAP P11-4, known as Curodont) to see if it can help repair early dental cavities and improve their appearance on X-rays.

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: Curodont Repair Fluoride Plus Treatment GroupExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Tripler Army Medical Center

Lead Sponsor

Trials
23
Recruited
27,900+